REAL-WORLD USE OF IMMUNOSUPPRESSIVES AMONG PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH VEDOLIZUMAB

被引：0
|
作者：
Raluy-Callado, Mireia
Carroll, Robert
Curtis, Rebecca
Khalid, Javaria Mona
Patel, Haridarshan
机构：
来源：
GASTROENTEROLOGY | 2018年 / 154卷 / 01期
关键词：
D O I：
10.1053/j.gastro.2017.11.249
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P190
引用
收藏
页码：S105 / S106
页数：2
相关论文
共 50 条
  • [21] Real-world use of faecal calprotectin testing in patients with inflammatory bowel disease
    Rubin, D. T.
    Yang, M.
    Wu, E. Q.
    Skup, M.
    Lee, W. -J.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S162 - S163
  • [22] Real World Experience of Vedolizumab in Pediatric Inflammatory Bowel Disease
    Whitney, Annette
    Sarles, Harry E., Jr.
    Claudia, Schroeder P.
    Okoro, Tracy C.
    Van Anglen, Lucinda J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S396 - S396
  • [23] Real-world efficacy and safety of vedolizumab among patients with inflammatory bowel disease: A single tertiary medical center experience in Central Taiwan
    Chiu, Yu-Chiao
    Chen, Chia-Chang
    Ko, Chung-Wang
    Liao, Szu-Chia
    Yeh, Hong-Zen
    Chang, Chung-Hsin
    ADVANCES IN DIGESTIVE MEDICINE, 2021, 8 (01) : 40 - 46
  • [24] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Mosli, Mahmoud
    Curtis, Rebecca
    Khalid, Javaria Mona
    Loftus, Edward Vincent, Jr.
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (09) : 1048 - 1064
  • [25] Systematic review with meta-analysis: real-world effectiveness and safety of vedolizumab in patients with inflammatory bowel disease
    Stefan Schreiber
    Axel Dignass
    Laurent Peyrin-Biroulet
    Greg Hather
    Dirk Demuth
    Mahmoud Mosli
    Rebecca Curtis
    Javaria Mona Khalid
    Edward Vincent Loftus
    Journal of Gastroenterology, 2018, 53 : 1048 - 1064
  • [26] Residual Disease Burden Among European Patients With Inflammatory Bowel Disease: A Real-World Survey
    Burisch, Johan
    Hart, Ailsa
    Sturm, Andreas
    Rudolph, Christine
    Meadows, Rachael
    Jus, Anna
    Dawod, Fatima
    Patel, Haridarshan
    Armuzzi, Alessandro
    INFLAMMATORY BOWEL DISEASES, 2024, 31 (02) : 411 - 424
  • [27] Real-World Effectiveness of Vedolizumab as Induction Therapy in Inflammatory Bowel Disease: A Meta-Analysis
    Schreiber, Stefan
    Dignass, Axel
    Peyrin-Biroulet, Laurent
    Hather, Greg
    Demuth, Dirk
    Khalid, Javaria
    Loftus, Edward, Jr.
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S24 - S24
  • [28] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    GASTROENTEROLOGY, 2019, 156 (03) : S36 - S37
  • [29] THERAPEUTIC DRUG MONITORING OF VEDOLIZUMAB FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE: REAL WORLD EXPERIENCE
    Shalabi, Ahmed
    Banerjee, Rwiti
    Padley, Jessica
    Appleby, Richard
    Johnston, Emma
    GUT, 2021, 70 : A120 - A120
  • [30] REAL WORLD EXPERIENCE IN THERAPEUTIC DRUG MONITORING IN INFLAMMATORY BOWEL DISEASE PATIENTS ON VEDOLIZUMAB
    Glassner, Kerri
    Irani, Malcolm
    Malaty, Hoda
    Abraham, Bincy P.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S26 - S26
12345